What is International Clinical Trials Day?

Celebrated on May 20th, it commemorates the world's first clinical trial conducted in 1747. It is a day to recognize the importance of clinical trials and to thank the participants, whose cooperation is essential.

What was the purpose of Triad Japan's online seminar?

The seminar aimed to address the daily concerns of individuals with schizophrenia and their families, provide accurate knowledge about treatment options and the latest trends, and explain the basics of new drug development and clinical trials.

Triad Japan is a Site Management Organization (SMO) founded in 1995 that supports medical institutions in conducting clinical trials, with a particular expertise in psychiatric and neurological fields like schizophrenia and Alzheimer's disease.

What were the results of the seminar according to the post-event survey?

The survey showed that over 90% of participants felt their understanding of schizophrenia treatment and clinical trials had deepened. Additionally, over 60% reported that their image of clinical trials had improved after attending.

What is PPI (Patient and Public Involvement)?

PPI is an initiative to incorporate the perspectives of patients and the public into medical research and development. Its importance is growing globally, promoting a model of 'healthcare created together with patients'.

AI News NQ Analysis

【5月20日國際臨床試驗日】Triad Japan公開思覺失調症線上研討會報告，作為PPI活動一環

NQ 評分 78/100

AI 摘要（NQ 加工版）

為紀念國際臨床試驗日，臨床試驗支援公司Triad Japan發表了一場成功的線上研討會報告，該活動旨在為思覺失調症患者及其家屬提供資訊。作為其PPI（病患及公眾參與）活動的一部分，該研討會加深了與會者對治療與臨床試驗的理解，並獲得超過九成參與者的正面評價。

AI 分析

常見問題

Q: What is International Clinical Trials Day?: A: Celebrated on May 20th, it commemorates the world's first clinical trial conducted in 1747. It is a day to recognize the importance of clinical trials and to thank the participants, whose cooperation is essential.
Q: What was the purpose of Triad Japan's online seminar?: A: The seminar aimed to address the daily concerns of individuals with schizophrenia and their families, provide accurate knowledge about treatment options and the latest trends, and explain the basics of new drug development and clinical trials.
Q: Who is Triad Japan?: A: Triad Japan is a Site Management Organization (SMO) founded in 1995 that supports medical institutions in conducting clinical trials, with a particular expertise in psychiatric and neurological fields like schizophrenia and Alzheimer's disease.
Q: What were the results of the seminar according to the post-event survey?: A: The survey showed that over 90% of participants felt their understanding of schizophrenia treatment and clinical trials had deepened. Additionally, over 60% reported that their image of clinical trials had improved after attending.
Q: What is PPI (Patient and Public Involvement)?: A: PPI is an initiative to incorporate the perspectives of patients and the public into medical research and development. Its importance is growing globally, promoting a model of 'healthcare created together with patients'.